Potential applications of siRNA in hepatitis C virus therapy

Current Opinion in Investigational Drugs

Volumn 7, Issue 2, 2006, Pages 142-146

  Smolic, Robert ^a   Volarevic, Martina ^a   Wu, Catherine H ^a   Wu, George Y ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Double stranded RNA; Gene therapy; Hepatitis C virus; RNA interference; Short interfering RNA

Indexed keywords

MESSENGER RNA; SINGLE STRANDED RNA; SMALL INTERFERING RNA; VIRUS RNA;

CYTOPLASM; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENE THERAPY; GENETIC TRANSFECTION; GENOME; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IN VITRO STUDY; LIVER CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PROTEIN SYNTHESIS; REVIEW; RNA INTERFERENCE; VIRUS REPLICATION;

ANIMALS; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; HEPACIVIRUS; HEPATITIS C; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA, VIRAL; VIRUS REPLICATION;

EID: 32544433440     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Elbashir SM, Lendeckel W, Tuschl T: RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev (2001) 15(2):188-200.
2. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T: Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J (2001) 20(23):6877-6888.
3. Hamilton AJ, Baulcombe DC: A species of small antisense RNA in posttranscriptional gene silencing in plants. Science (1999) 286(5441):950-952.
4. Napoli C, Lemieux C, Jorgensen R: Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell (1990) 2(4):279-289.
5. Romano N, Macino G: Quelling: Transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences. Mol Microbiol (1992) 6(22):3343-3353.
6. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 391(6669):806-811.
7. Kennerdell JR, Carthew RW: Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell (1998) 95(7):1017-1026.
8. Misquitta L, Paterson BM: Targeted disruption of gene function in Drosophila by RNA interference (RNA-i): A role for nautilus in embryonic somatic muscle formation. Proc Natl Acad Sci USA (1999) 96(4):1451-1456.
9. Ngo H, Tschudi C, Gull K, Ullu E: Double-stranded RNA induces mRNA degradation in Trypanosoma brucei. Proc Natl Acad Sci USA (1998) 95(25):14687-14692.
10. Elbashir SM, Harborth J, Weber K, Tuschl T: Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods (2002) 26(2):199-213.
11. Wianny F, Zernicka-Goetz M: Specific interference with gene function by double-stranded RNA in early mouse development. Nat Cell Biol (2000) 2(2):70-75.
12. Yang S, Tutton S, Pierce E, Yoon K: Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol Cell Biol (2001) 21(22):7807-7816.
13. Zamore PD, Tuschl T, Sharp PA, Bartel DP: RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell (2000) 101(1):25-33.
14. Olsen PH, Ambros V: The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol (1999) 216(2):671-680.
15. Tang G, Reinhart BJ, Bartel DP, Zamore PD: A biochemical framework for RNA silencing in plants. Genes Dev (2003) 17(1):49-63.
16. Volpe TA, Kidner C, Hall IM, Teng G, Grewal SI, Martienssen RA: Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science (2002) 297(5588):1833-1837.
17. Hall IM, Shankaranarayana GD, Noma K, Ayoub N, Cohen A, Grewal SI: Establishment and maintenance of a heterochromatin domain. Science (2002) 297(5590):2232-2237.
18. Mochizuki K, Fine NA, Fujisawa T, Gorovsky MA: Analysis of a piwi-related gene implicates small RNAs in genome rearrangement in tetrahymena. Cell (2002) 110(6):689-699.
19. Bosher JM, Labouesse M: RNA interference: Genetic wand and genetic watchdog. Nat Cell Biol (2000) 2(2):E31-E36.
20. Hannon GJ: RNA interference. Nature (2002) 418(6894):244-251.
21. Bernstein E, Caudy AA, Hammond SM, Hannon GJ: Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature (2001) 409(6818):363-366.
22. Nykanen A, Haley B, Zamore PD: ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell (2001) 107(3):309-321.
23. Hammond SM, Bernstein E, Beach D, Hannon GJ: An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature (2000) 404(6775):293-296.
24. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (2001) 411(6836):494-498.
25. Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA: Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA (2001) 98(17):9742-9747.
26. Billy E, Brondani V, Zhang H, Muller U, Filipowicz W: Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines. Proc Natl Acad Sci USA (2001) 98(25):14428-14433.
27. Hamilton A, Voinnet O, Chappell L, Baulcombe D: Two classes of short interfering RNA in RNA silencing. EMBO J (2002) 21(17):4671-4679.
28. Morris MC, Vidal P, Chaloin L, Heitz F, Divita G: A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res (1997) 25(14):2730-2736.
29. Simeoni F, Morris MC, Heitz F, Divita G: Insight into the mechanism of the peptide-based gene delivery system MPG: Implications for delivery of siRNA into mammalian cells. Nucleic Acids Res (2003) 31(11):2717-2724.
30. Simecni F, Morris MC, Heitz F, Divita G: Peptide-based strategy for siRNA delivery into mammalian cells. Methods Mol Biol (2005) 309:251-260.
31. Hoofnagle JH: Course and outcome of hepatitis C. Hepatology (2002) 36(5 Suppl 1):S21-S29.
32. Fishman JA, Rubin RH, Koziel MJ, Periera BJ: Hepatitis C virus and organ transplantation. Transplantation (1996) 62(2):147-154.
33. World Health Organization: Hepatitis C: Global prevalence. Wkly Epidemiol Rec (1997) 72(46):341-344.
34. Alter HJ, Seeff LB: Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome. Semin Liver Dis (2000) 20(1):17-35.
35. Bowen DG, Walker CM: The origin of quasispecies: Cause or consequence of chronic hepatitis C viral infection? J Hepatol (2005) 42(3):408-417.
36. Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM: Structural biology of hepatitis C virus. Hepatology (2004) 39(1):5-19.
37. Lohmann V, Koch JO, Bartenschlager R: Processing pathways of the hepatitis C virus proteins. J Hepatol (1996) 24(2 Suppl):11-19.
38. Moradpour D, Brass V, Bieck E, Friebe P, Gosert R, Blum HE, Bartenschlager R, Penin F, Lohmann V: Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication. J Virol (2004) 78(23):13278-13284.
39. Kronke J, Kittler R, Buchholz F, Windisch MP, Pietschmann T, Bartenschlager R, Frese M: Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs. J Virol (2004) 78(7):3436-3446.
40. Kapadia SB, Brideau-Andersen A, Chisari FV: Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci USA (2003) 100(4):2014-2018.
41. Yokota T, Sakamoto N, Enomoto N, Tanabe Y, Miyagishi M, Maekawa S, Yi L, Kurosaki M, Taira K, Watanabe M, Mizusawa H: Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep (2003) 4(6):602-608.
42. Wilson JA, Jayasena S, Khvorova A, Sabatinos S, Rodrigue-Gervais IG, Arya S, Sarangi F, Harris-Brandts M, Beaulieu S, Richardson CD: RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc Natl Acad Sci USA (2003) 100(5):2783-2788.
43. Randall G, Grakoui A, Rice CM: Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc Natl Acad Sci USA (2003) 100(1):235-240.
44. Seo MY, Abrignani S, Houghton M, Han JH: Small interfering RNA-mediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7. J Virol (2003) 77(1):810-812.
45. Prabhu R, Vittal P, Yin Q, Flemington E, Gerry R, Robichaux WH, Dash S: Small interfering RNA effectively inhibits protein expression and negative strand RNA synthesis from a full-length hepatitis C virus clone. J Med Virol (2005) 76(4):511-519.
46. Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P, Lieberman J: RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med (2003) 9(3):347-351.
47. Lewis DL, Wolff JA: Delivery of siRNA and siRNA expression constructs to adult mammals by hydrodynamic intravascular injection. Methods Enzymol (2005) 392:336-350.
48. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA: RNA interference in adult mice. Nature (2002) 418(6893):38-39.
49. Chang KS, Luo G: The polypyrimidine tract-binding protein (PTB) is required for efficient replication of hepatitis C virus (HCV) RNA. Virus Res (2006) 115(1):1-8.
50. Domitrovich AM, Diebel KW, Ali N, Sarker S, Siddiqui A: Role of La autoantigen and polypyrimidine tract-binding protein in HCV replication. Virology (2005) 335(1):72-86.
51. Hamamoto I, Nishimura Y, Okamoto T, Aizaki H, Liu M, Mori Y, Abe T, Suzuki T, Lai MM, Miyamura T, Moriishi K, Matsuura Y: Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. J Virol (2005) 79(21):13473-13482.
52. Lan S, Wang H, Jiang H, Mao H, Liu X, Zhang X, Hu Y, Xiang L, Yuan Z: Direct interaction between α-actinin and hepatitis C virus NS5B. FEBS Lett (2003) 554(3):289-294.
53. Mannova P, Beretta L: Activation of the N-Ras-PI3K-Akt-mTOR pathway by hepatitis C virus: Control of cell survival and viral replication. J Virol (2005) 79(14):8742-8749.
54. Wilson JA, Richardson CD: Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region. J Virol (2005) 79(11):7050-7058.
55. De Francesco R, Migliaccio G: Challenges and successes in developing new therapies for hepatitis C. Nature (2005) 436(7053):953-960.
56. Jarczak D, Korf M, Beger C, Manns MP, Kruger M: Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons. FEBS J (2005) 272(22):5910-5922.
57. Braasch DA, Paroo Z, Constantinescu A, Ren G, Oz OK, Mason RP, Corey DR: Biodistribution of phosphodiester and phosphorothioate siRNA. Bioorg Med Chem Lett (2004) 14(5):1139-1143.